Hui-Hsuan Liu

Hui-Hsuan Liu

Auto-generated profile, based on publicly available information

Hui-Hsuan Liu

Department of Comparative Biomedical Sciences, Royal Veterinary College, London NW1 0TU, UK

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2023 in Animals
Verified
Journal Article
Open access
PDF file
Wan-Ching ChengWan-Ching Cheng
Wan-Ching Cheng
CLCharlotte Lawson
Charlotte Lawson
HLHui-Hsuan Liu
Hui-Hsuan Liu
LWLois Wilkie
Lois Wilkie
MDMelanie Jo Dobromylskyj
Melanie Jo Dobromylskyj
DCDavid J Connolly
David J Connolly
Hypertrophic cardiomyopathy (HCM) affects both humans and cats and exhibits considerable interspecies similarities that are exemplified by underlying pathological processes and clinical presentation to the extent that developments in the human field may have direct relevance to the feline disease. Characteristic changes on histological examination include cardiomyocyte hypertrophy and interstitial and replacement fibrosis. Clinically, HCM is characterised by significant diastolic dysfunction due to a reduction in ventricular compliance and relaxation associated with extracellular matrix (ECM) remodelling and the development of ventricular hypertrophy. Studies in rodent models and human HCM patients have identified key protein mediators implicated in these pathological changes, including lumican, lysyl oxidase and TGF-β isoforms. We therefore sought to quantify and describe the cellular location of these mediators in the left ventricular myocardium of cats with HCM and investigate their relationship with the quantity and structural composition of the ECM. We identified increased myocardial content of lumican, LOX and TGF-β2 mainly attributed to their increased expression within cardiomyocytes in HCM cats compared to control cats. Furthermore, we found strong correlations between the expressions of these mediators that is compatible with their role as important components of cellular pathways promoting remodelling of the left ventricular myocardium. Fibrosis and hypertrophy are important pathological changes in feline HCM, and a greater understanding of the mechanisms driving this pathology may facilitate the identification of potential therapies.